Automatic balloon inflation apparatus for transcatheter heart valve implantation

By pushing fluid in the balloon catheter and monitoring pressure, and automatically controlling the inflation and deflation of the balloon, the problems of inconsistent balloon dilation and cumbersome manual degassing process in the prior art are solved, and a more efficient and reliable heart valve is achieved Implantation and equipment preparation.

CN119095555APending Publication Date: 2024-12-06ST JUDE MEDICAL CARDILOGY DIV INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202380036090.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-05-18
Filing Date
2023-05-03
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

Existing balloon-expandable artificial heart valves are not consistent and predictable enough during manual inflation, and are difficult to automate, and need to be manually degassed before use to ensure no residual air in the catheter, which is cumbersome and visually dependent. Check, there is a risk of error.

Method used

Using a method and system, by pushing fluid in the balloon catheter to inflate and monitor pressure, displaying pressure data in real time, and using a motor to drive the plunger handle to automatically control the inflation and deflation of the balloon, ensuring the balloon’s expansion Pressure consistency and safety; at the same time, the automated degassing process is monitored through vacuum pressure and plunger displacement to ensure that the amount of air in the conduit is at an acceptable level.

Benefits of technology

Achieve more consistent and predictable expansion of balloons in heart valve implantation, reduces uncertainty in manual operation, improves the degree of automation of the inflation process, and reduces the risk of error through automated degassing process, ensuring the equipment's Safe and effective use.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119095555A_ABST
    Figure CN119095555A_ABST
Patent Text Reader

Abstract

A method of implanting a prosthetic heart valve includes delivering the prosthetic heart valve to a native valve annulus while crimping the prosthetic heart valve on a deflated balloon of a delivery device. The method may include propelling fluid through a delivery device and into a balloon to inflate the balloon and expand the prosthetic heart valve into the native valve annulus. The method may include monitoring a pressure within the delivery device while propelling the fluid through the delivery device. The method may also include displaying the monitored pressure on a display device in real time during monitoring of the pressure.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] CROSS-REFERENCE TO RELATED APPLICATIONS

[0002] This application claims priority to U.S. Provisional Patent Application No. 63 / 343,479, filed on May 18, 2022, the contents of which are incorporated herein by reference. Background Art

[0003] Valvular heart disease, particularly aortic valve disease and mitral valve disease, is a significant health problem in the United States. Valve replacement is an option for treating valvular heart disease. Artificial heart valves, including surgical heart valves and foldable / expandable heart valves intended for transcatheter aortic valve replacement ("TAVR") or transcatheter mitral valve replacement ("TMVR"), are well known in the patent literature. For example, a surgical heart valve or a mechanical heart valve can be sutured to the patient's native valve annulus during an open heart surgical procedure. The foldable / expandable heart valve can be delivered to the patient via a tubular delivery device (such as a catheter, a trocar, a laparoscopic instrument, etc.) to avoid more invasive surgery (such as full-chest surgery, open heart surgery). As used herein, reference to a "foldable / expandable" heart valve includes heart valves formed with a small cross-section that enable the heart valve to be delivered to a patient via a tubular delivery device in a minimally invasive procedure and then expanded to an operable state once in place, as well as heart valves that are first folded into a small cross-section after construction for delivery to a patient and then expanded to an operable size once in place in the valve annulus.

[0004] Foldable / expandable artificial heart valves are usually in the form of a one-way valve structure (generally referred to herein as a valve assembly) mounted in an expandable stent / expandable stent. Typically, these foldable / expandable heart valves include a self-expanding or balloon-expandable stent, which is usually made of nitinol or another shape memory metal or metal alloy (for self-expanding stents) or steel or cobalt chromium (for balloon-expandable stents). Known existing foldable / expandable TAVR devices use different configurations of stent layouts - including straight vertical struts connected by "V" as shown in U.S. Patent No. 8,454,685, or a diamond unit layout as shown in U.S. Patent No. 9,326,856, both of which are incorporated herein by reference. The one-way valve assembly mounted in the stent / stent includes one or more blades and may also include a cuff or skirt. The cuff can be set on the inner surface or lumen surface of the stent, its outer surface or lumen outer surface and / or on both surfaces. The cuff helps ensure that blood does not just flow around the valve leaflets if the valve or valve component is not optimally seated in the valve annulus. The cuff or a portion of the cuff disposed on the outside of the stent can help slow leakage around the outside of the valve (the latter is called paravalvular leakage or "PV" leakage).

[0005] The balloon expandable valve is typically delivered to the native annulus while being folded (or "curled") onto the deflated balloon of a balloon catheter, with the folded valve being covered or uncovered by an overlying sheath. Once the curled artificial heart valve is positioned within the annulus of the replaced native heart valve, the balloon is inflated to force the balloon expandable valve to transition from a folded or curled state to an expanded or deployed state, wherein the artificial heart valve tends to remain in the shape into which it was expanded by the balloon. Typically, when the position of the folded artificial heart valve is determined to be in a desired position relative to the native annulus (e.g., via visualization under fluoroscopy), a fluid (typically a liquid, but gas may also be used) such as saline is pushed through the balloon catheter via a manual syringe to begin filling and expanding the balloon, thereby expanding the overlying artificial heart valve into the native annulus. Complete reliance on manual balloon inflation may not be optimal, and it may be desirable to partially or completely automate the balloon inflation process, for example, to provide more consistent and predictable balloon inflation results. For example, the predictability of how a balloon-expandable artificial heart valve expands can vary greatly depending on the speed at which the balloon is inflated by the user. Such a system can also be able to assist in providing data that can be used during surgery, and this data can also be collected in many surgeries to learn information about important parameters of balloon inflation that may not be easily determined from a typical manual process. This information can be collected and used to improve a partial or complete automated balloon expansion process for future surgeries. It can also be desirable that the balloon inflation system (or its accessory components) can reliably degas the balloon catheter system before use, preferably using an objective mechanism (e.g., in addition to visual inspection alone) to confirm that the air remaining in the catheter does not exceed an acceptable amount before delivery. Summary of the invention

[0006] According to one aspect of the present disclosure, a method for implanting an artificial heart valve includes delivering the artificial heart valve to a native valve annulus while curling the artificial heart valve on a deflated balloon of a delivery device. The method may include advancing a fluid through the delivery device and into the balloon to inflate the balloon and expand the artificial heart valve into the native valve annulus. The method may include monitoring the pressure within the delivery device while advancing the fluid through the delivery device. The method may also include displaying the monitored pressure in real time on a display device during the monitoring of the pressure.

[0007] According to another aspect of the present disclosure, an artificial heart valve delivery system may include a handle, a balloon catheter extending from the handle, and a balloon positioned at a distal portion of the balloon catheter. A fluid reservoir may be in fluid communication with a lumen that is in fluid communication with an internal volume of the balloon. A motor may be operably coupled to the fluid reservoir. An actuator may be disposed on the handle, the actuator operably coupled to the motor so that actuation of the actuator in a first direction causes the motor to push fluid from the fluid reservoir through the lumen toward the internal volume of the balloon, and actuation of the actuator in a second direction opposite to the first direction causes the motor to withdraw fluid from the internal volume of the balloon toward the fluid reservoir.

[0008] According to another embodiment of the present disclosure, a method for degassing a balloon of a balloon catheter may include (i) withdrawing a plunger of a purge syringe when the purge syringe is in fluid communication with the balloon of the balloon catheter and the purge syringe is not in fluid communication with a filling syringe containing a fluid, and monitoring vacuum pressure as a function of plunger displacement when the plunger of the purge syringe is withdrawn to create a pressure displacement line having a slope. The method may also include (ii) advancing the plunger of the filling syringe when the filling syringe is in fluid communication with the balloon of the balloon catheter and the filling syringe is not in fluid communication with the purge syringe. The method may also include (iii) advancing the plunger of the filling syringe when the filling syringe is in fluid communication with the purge syringe and the filling syringe is not in fluid communication with the balloon catheter to push the remaining air through a one-way valve in fluid communication with the purge syringe. Steps (i) to (iii) may be repeated until the slope of the pressure-displacement line exceeds a threshold slope of the reference pressure-displacement line. BRIEF DESCRIPTION OF THE DRAWINGS

[0009] Figure 1A is a perspective view of a stent for an artificial heart valve according to an embodiment of the present disclosure.

[0010] Figure 1B yes Figure 1A Schematic front view of a section of a bracket.

[0011] Figure 1C is based on Figure 1A Schematic front view of a segment of a stent of an alternative embodiment of an artificial heart valve.

[0012] Figure 1D to Figure 1E They are Figure 1C Front view of the stent segment in a folded state and an expanded state.

[0013] Figure 1F to Figure 1G According to Figure 1C A side view of a portion of a stent of an embodiment in a folded state and an expanded state.

[0014] Figure 1H is based on Figure 1C A flattened view of a stent of an embodiment of the invention as if it had been cut and flattened.

[0015] Figures 1I to 1J They include Figure 1C Front view and side view of an artificial heart valve with a stent.

[0016] Figure 2A is a highly schematic diagram of a balloon inflation system according to one aspect of the present disclosure.

[0017] Figure 2B yes Figure 2A A highly schematic diagram of the rapid fluid withdrawal mechanism of the balloon inflation system.

[0018] FIG. 3A to FIG. 3B 4 are a top view and a side view, respectively, of a balloon inflation system according to another aspect of the present disclosure.

[0019] Figure 3C is connected to FIG. 3A to FIG. 3B A perspective view of a handle of a delivery device of a balloon inflation system.

[0020] FIG. 3D to FIG. 3E yes Figure 3C A view of the handle of the delivery device.

[0021] Figure 3F is curled in Figure 3C Side view of a prosthetic heart valve on a deflated balloon of a delivery device.

[0022] Figure 3G It is inflated Figure 3E Illustration of the balloon.

[0023] Figure 3H An exemplary pressure sensor for use with a balloon is provided. Figure 3G Illustration of the balloon.

[0024] Fig. 3I is an exemplary strain gauge for use on a balloon Figure 3G Illustration of the balloon.

[0025] Figure 4 It's a picture. Figure 3F to Figure 3G The balloon compliance curve of the balloon pressure and volume.

[0026] Figure 5 is a highly schematic illustration of the interaction between the various elements involved in implanting a prosthetic heart valve using the devices described herein.

[0027] Fig. 6Aare exemplary display screens during the planning steps of a prosthetic heart valve implant.

[0028] Figure 6B are exemplary display screens during steps in a procedure for implanting a prosthetic heart valve.

[0029] Figure 7 is a highly schematic illustration of a degassing system according to one aspect of the present disclosure.

[0030] Figure 8 is a graph illustrating the slope of vacuum pressure versus syringe displacement during the degassing process. DETAILED DESCRIPTION

[0031] As used herein, when used in conjunction with an artificial heart valve, the term "inflow end" refers to the end of the artificial valve that blood first enters when the artificial valve is implanted in the expected position and orientation, and the term "outflow end" refers to the end of the artificial valve that blood leaves when the artificial valve is implanted in the expected position and orientation. Further, for an artificial aortic valve, the inflow end is the end closer to the left ventricle, and the outflow end is the end closer to the aorta. The expected position and orientation are used for convenience in describing the valve disclosed herein, however, it should be noted that the use of the valve is not limited to the expected position and orientation, but can be deployed in any type of lumen or channel. For example, although the artificial heart valve is described herein as an artificial aortic valve, the same or similar structures and features can be used for other heart valves, (e.g., pulmonary valves, mitral valves, or tricuspid valves). Further, when used in conjunction with a delivery device or system, the term "proximal end" refers to the direction relatively close to the user of the device or system when used as intended, and the term "distal end" refers to the direction relatively far from the user of the device. In other words, when used as intended, the front end of the delivery device or system is positioned distal to the rear end of the delivery device or system. As used herein, the terms "substantially," "generally," "approximately," and "about" are intended to indicate that slight deviations from the absolute values ​​are also included within the scope of the modified terms. As used herein, a stent can assume an "expanded state" and a "folded state," which refers to the relative radial dimensions of the stent.

[0032] Figure 1AThe stereogram of the stent 100 of the artificial heart valve according to the embodiment of the present disclosure is illustrated. The stent 100 may include a frame extending in an axial direction between an inflow end 101 and an outflow end 103. The stent 100 includes three generally symmetrical sections, wherein each section spans about 120 degrees around the circumference of the stent 100. The stent 100 includes three vertical struts 110a, 110b, 110c, which extend in an axial direction substantially parallel to the direction of blood flow through the stent, which axial direction may also be referred to as a central longitudinal axis. Each vertical strut 110a, 110b, 110c may extend substantially over the entire axial length between the inflow end 101 and the outflow end 103 of the stent 100, and may be disposed between two sections and shared by the two sections. In other words, each section is defined by the portion of the stent 100 between the two vertical struts. Furthermore, each vertical strut 110a, 110b, 110c is also separated by about 120 degrees around the circumference of the stent 100. It should be understood that if the stent 100 is used in an artificial heart valve with three leaves, the stent may include three sections as shown. However, in other embodiments, if the artificial heart valve has two leaves, the stent may only include two of the sections.

[0033] Figure 1B Illustrated is a schematic diagram of a stent segment 107 of stent 100 , which will be described in greater detail herein and is representative of all three segments. Figure 1BThe support segment 107 depicted in FIG. 1 includes a first vertical strut 110a and a second vertical strut 110b. The first vertical strut 110a extends axially between the first inflow node 102a and the first external node 135a. The second vertical strut 110b extends axially between the second inflow node 102b and the second external node 135b. As shown, the vertical struts 110a, 110b can extend over almost the entire axial length of the support 100. In some embodiments, the support 100 can be formed as an integral unit, such as by cutting the support from a tube with a laser. The term "node" can refer to the place where two or more struts of the support 100 meet each other. A pair of sequential inverted V-shaped inverted V-shaped inverted V-shaped 120a and a second inflow inverted V-shaped 120b connected to each other at the inflow node 105. The first inflow inverted V-shaped 120a includes a first outer lower strut 122a extending between the first inflow node 102a and the first central node 125a. The first inflow inverted V-shape 120a also includes a first inner lower strut 124a extending between the first center node 125a and the inflow node 105. The second inflow inverted V-shape 120b includes a second inner lower strut 124b extending between the inflow node 105 and the second center node 125b. The second inflow inverted V-shape 120b also includes a second outer lower strut 122b extending between the second center node 125b and the second inflow node 102b. Although described as inverted V-shapes, these structures can also be described as half units, each half unit being a half diamond unit, wherein the opening portion of the half unit is located at the inflow end 101 of the stent 100.

[0034] The support segment 107 further includes a first center support 130a extending between the first center node 125a and the upper node 145. The support segment 107 also includes a second center support 130b extending between the second center node 125b and the upper node 145. The first center support 130a, the second center support 130b, the first inner lower support 124a, and the second inner lower support 124b form a diamond unit 128. The support segment 107 includes a first outer upper support 140a extending between the first outer node 135 and the first outflow node 104a. The support segment 107 further includes a second outer upper support 140b extending between the second outer node 135b and the second outflow node 104b. The support segment 107 includes a first inner upper support 142a extending between the first outflow node 104a and the upper node 145. The support segment 107 further includes a second inner upper support 142b extending between the upper node 145 and the second outflow node 104b. The support section 107 includes an outflow inverted V-shape 114 extending between a first outflow node 104a and a second outflow node 104b. The first vertical strut 110a, the first outer upper strut 140a, the first inner upper strut 142a, the first center strut 130a, and the first outer lower strut 122a form a first overall kite-shaped unit 133a. The second vertical strut 110b, the second outer upper strut 140b, the second inner upper strut 142b, the second center strut 130b, and the second outer lower strut 122b form a second overall kite-shaped unit 133b. The first kite-shaped unit 133a and the second kite-shaped unit 133b are symmetrical and opposite to each other on the support section 107. Although the term "kite-shaped" is used above, it should be understood that this shape is not limited to the precise geometric definition of a kite shape. The outflow inverted V-shape 114, the first inner upper strut 142a, and the second inner upper strut 142b form an upper unit 134. The upper cell 134 is generally kite-shaped and axially aligned with the diamond-shaped cells 128 on the stent segment 107. It should be understood that, although designated as individual struts, the various struts described herein can be part of a single unitary structure as described above. However, in other embodiments, the stent 100 need not be formed as a unitary structure, and thus the struts can be different structures (or parts of different structures) coupled together.

[0035] Figure 1CA schematic diagram of a support segment 207 according to an alternative embodiment of the present disclosure is illustrated. Unless otherwise noted, like reference numerals refer to elements similar to those in support segment 100 described above but with 200-series reference numerals. Support segment 207 is substantially similar to support segment 107, including inflow nodes 202a, 202b, vertical struts 210a, 210b, first inflow inverted V-shapes 220a and second inflow inverted V-shapes 220b, and outflow nodes 204a, 204b. The structure of support segment 207 differs from that of support segment 107 in that it does not include an outflow inverted V-shape. Having Figure 1C The purpose of this embodiment of the structure of the stent segment 207 shown in the embodiment is to reduce the force required to expand the outflow end 203 of the stent 200 compared to the stent 100 to promote uniform expansion relative to the inflow end 201. The outflow nodes 204a, 204b are connected by a properly oriented V-shape formed by the first internal upper strut 242a, the upper node 245 and the second internal upper strut 242b. In other words, the struts 242a, 242b can form a half-diamond unit 234, wherein the open end of the half unit is oriented toward the outflow end 203. The half-diamond unit 234 is axially aligned with the diamond unit 228. Adding the outflow inverted V-shape connected between the outflow nodes 204a, 204b helps to increase the additional material that modifies the resistance of the stent shape, and requires additional force to expand the stent. Excluding material from the outflow end 203 reduces the expansion resistance on the outflow end 203, which can promote uniform expansion of the inflow end 201 and the outflow end 203. In other words, the inflow end 201 of the stent 200 does not include a continuous circumferential structure, but rather has a half-unit that is mostly or completely open, wherein the open portion of the half-unit is oriented toward the inflow end 201, and the majority of the outflow end 203 includes a substantially continuous circumferential structure via struts corresponding to struts 140a, 140b. All other things being equal, a substantially continuous circumferential structure may require greater force to expand than a similar but open structure. Furthermore, the inflow end 101 of the stent 100 may require greater force to expand radially than the outflow end 103. By omitting the inverted V-shape 114, a stent 200 is obtained in which the force required to expand the outflow end 203 of the stent 200 can be reduced to an amount closer to the inflow end 201.

[0036] Figure 1D shows a front view of the support section 207 in a folded state, and Figure 1E 207 is shown in a front view of the stent segment 207 in an expanded state. It should be understood that Figure 1D to Figure 1EThe stent 200 in FIG. 1 is illustrated with an opaque tube extending through the interior of the stent, purely to help illustrate the stent, and this may represent the balloon on which the stent segment 207 is crimped. As described above, the stent includes three symmetrical segments, each spanning approximately 120 degrees around the circumference of the stent. Figure 1D to Figure 1E The support segment 207 shown in FIG. 2 is defined by the area between the vertical struts 210a, 210b. The support segment 207 represents all three segments of the support. The support segment 207 has an arc-shaped structure so that when the three segments are connected, they form a complete cylindrical shape. Figure 1F to Figure 1G A portion of the bracket is shown in a side view. Figure 1D to Figure 1E Compared with the view Figure 1F to Figure 1G The view of the bracket 200 in FIG. 1 is rotated approximately 60 degrees. Figure 1F to Figure 1G The view of the stent depicted in FIG is centered on a vertical strut 210b, showing approximately half of each of the two adjacent stent segments 207a, 207b located on each side of the vertical strut 210b. The segments 207a, 207b surrounding the vertical strut 210b are mirror images of each other. Figure 1F The support sections 207a, 207b are shown in a folded state, and Figure 1G Stent segments 207a, 207b are shown in an expanded state.

[0037] Figure 1H A flattened view of a support 200 comprising three support sections 207a, 207b, 207c is illustrated, as if the support had been cut longitudinally and laid flat on a table. As depicted, the sections 207a, 207b, 207c are symmetrical to each other, and adjacent sections share a common vertical support. As described above, the support 200 is shown in a flattened view, but each section 207a, 207b, 207c has an arc spanning 120 degrees to form a complete cylinder. Figure 1H 250a, 250b, 250c are further depicted coupled to the bracket 200. However, it should be understood that Figure 1H Only the connection of the blades 250a, 250b, 250c is illustrated in the figure. In other words, each blade 250a, 250b, 250c generally includes a free edge, wherein the free edges are used to engage with each other to prevent retrograde blood flow through the stent 200, and the free edges move radially outward toward the inner surface of the stent to allow antegrade blood flow through the stent. These free edges are not shown in the figure. Figure 1H In contrast, the attachment edges of blades 250a, 250b, 250c are Figure 1H250a, 250b, 250c. Each of the three blades 250a, 250b, 250c extends about 120 degrees from one end to the other around the support 200, and each blade includes a belly that can extend toward the radial center of the support 200 when the blades are joined together. Each blade extends between the upper nodes of adjacent sections. The first blade 250a extends from the first upper node 245a of the first support segment 207a to the second upper node 245b of the second support segment 207b. The second blade 250b extends from the second upper node 245b to the third upper node 245c of the third support segment 207c. The third blade 250c extends from the third upper node 245c to the first upper node 245a. Therefore, each upper node includes a first end of a first blade and a second end of a second blade coupled thereto. In the illustrated embodiment, each end of each blade is coupled to its respective node by suturing. However, any coupling device can be used to attach the blade to the support. It is also conceivable that the support may include any number of segments and / or blades. For example, the support may include two segments, each of which extends 180 degrees around the circumference of the support. Further, the support may include two blades to simulate a bicuspid valve. In addition, it should be noted that each blade may include a protrusion or other structure (not shown) at the junction between the free edge and the attachment edge of the blade, and each protrusion of each blade may be coupled to the protrusion of an adjacent blade to form a joint. In the illustrated embodiment, the blade joint is illustrated as being attached to the node where the pillars intersect. However, in other embodiments, the support 200 may include a joint attachment feature that is built into the support to facilitate such attachment. For example, commissure attachment features can be formed into the stent 200 at nodes 245a, 245b, 245c, wherein the commissure attachment features include one or more holes to facilitate suturing the leaf commissures to the stent. In addition, the leaves 250a, 250b, 250c can be formed of a biological material (such as animal pericardium), or can be formed of a synthetic material (such as ultra-high molecular weight polyethylene (UHMWPE)).

[0038] Figures 1I to 1JAn artificial heart valve 206 is shown, which includes a stent 200, a cuff 260 coupled to the stent 200 (e.g., via sutures), and leaflets 250a, 250b, 250c attached to the stent 200 and / or the cuff 260 (e.g., via sutures). The artificial heart valve 206 is intended for use in replacing the aortic valve, but the same or similar structure can be used in artificial valves for replacing other heart valves. The cuff 260 is disposed on the lumen or inner surface of the stent 200, but the cuff can be alternatively or additionally disposed outside the lumen or on the outer surface of the stent. The cuff 250 may include an inflow end disposed substantially along the inflow end 201 of the stent 200. Fig. 1I A front view of the valve 206 is shown, which shows a stent portion 207 between the vertical struts 210a, 210b of the cuff 260 and the profile of two blades 250a, 250b sutured to the cuff 260. Different methods of suturing the blades to the cuff and suturing the blades and / or cuffs to the stent can be used, many of which are described in U.S. Patent No. 9,326,856, which is incorporated herein by reference. In the illustrated embodiment, the upper (or outflow) edge of the cuff 260 is sutured to the first central node 225a, the upper node 245 and the second central node 225b, extending along the first central strut 230a and the second central strut 230b. The upper (or outflow) edge of the cuff 260 continues to extend roughly between the second central node of a segment and the first central node of the adjacent segment. The cuff 260 extends between the upper node 245 and the inflow end 201. Furthermore, the cuff 260 covers the cells of the stent portion 207 formed by struts between the upper nodes 245 and the inflow end 201 , including the diamond-shaped cells 228 . Figure 1J 2 shows a side view of the support 200, including the outlines of the cuff 260 and the blade 250b. Fig. 1I Compared with the view Figure 1J The view of valve 206 in FIG. 2 is rotated approximately 60 degrees. Figure 1J The view depicted in is centered on the vertical strut 210b and shows approximately half of each of the two adjacent stent segments 207a, 207b located on each side of the vertical strut 210b. The segments 207a, 207b surrounding the vertical strut 210b are mirror images of each other. As described above, the cuff can be disposed on an inner or luminal surface of the stent, an outer or luminal surface thereof, and / or both surfaces. The cuff ensures that blood does not flow solely around the valve leaflets if the valve or valve assembly is not optimally seated in the valve annulus. The cuff, or a portion of the cuff disposed on the exterior of the stent, can help slow leakage around the exterior of the valve (the latter being referred to as paravalvular leakage or "PV" leakage). In the Figures 1I to 1JIn the illustrated embodiment, the cuff 260 only covers about half of the stent 200, so that about half of the stent is not covered by the cuff. Compared with the cuff covering most or all of the stent 200, the cuff material required by this configuration is less. Less cuff material can allow the artificial heart valve 206 to curl down to a smaller profile when folded. It is conceivable that the cuff can cover the surface area of ​​any size of the cylinder formed by the stent. For example, the upper edge of the cuff can extend straightly around the circumference of any cross section of the cylinder formed by the stent. The cuff 260 can be formed by any suitable material, including biomaterials such as animal pericardium, or synthetic materials (e.g., UHMWPE).

[0039] The stent can be formed of biocompatible materials, including metals and metal alloys (e.g., cobalt chromium (or cobalt chromium alloy) or stainless steel), but in some embodiments, the stent can be formed of a shape memory material (e.g., nitinol, etc.). The stent is further configured to fold when curled to a smaller diameter and / or expand when forced to open, such as via a balloon expansion within the stent, and the stent will substantially remain in its modified shape when at rest. The stent can be curled to fold in the radial direction and elongate in the axial direction (to some extent), thereby reducing its profile at any given cross-section. The stent can also expand in the radial direction and shorten in the axial direction (to some extent).

[0040] Artificial heart valves can be delivered via any suitable transvascular approach (e.g., including transapical approach or transfemoral approach). Typically, transapical approach delivery uses a relatively hard catheter to penetrate the patient's chest and pierce the apex of the left ventricle, which can cause a relatively large degree of trauma compared to delivery via the femoral approach. In delivery via the femoral approach, the delivery device that accommodates the valve is inserted through the femoral artery and resists blood flow to the left ventricle. In either delivery method, the valve can be folded on an expandable balloon at first, and the expandable balloon is deflated at the same time. The balloon can be connected to a delivery system or arranged in a delivery system, and the delivery system can transport the valve through the body and the heart to reach the aortic valve, and the valve is arranged above the balloon (and in some cases, arranged below the covering sheath). When arriving at the aortic valve or adjacent to the aortic valve, the surgeon or operator of the delivery system can align the artificial valve as desired in the natural valve ring, while the artificial valve is folded on the balloon. When the desired alignment is achieved, the covering sheath (if included) can be withdrawn (or advanced) to expose the prosthetic valve, and the balloon can be inflated to expand the prosthetic valve in a radial direction with at least a portion of the prosthetic valve shortened in an axial direction.

[0041] Although certain embodiments of balloon-expandable prosthetic heart valves are provided above, it should be understood that the systems, devices and methods described below for inflating, deflating and / or degassing the balloon of a balloon catheter can be used with other types of balloon-expandable prosthetic heart valves than those described above.

[0042] Reference now Figure 2A , illustrates an embodiment of an automatic balloon inflation device 300. In the illustrated embodiment, the balloon inflation device may include a housing in which a syringe 305 is securely received. The housing may fix the body of the syringe 305 to the housing in a fixed relationship, wherein the plunger handle of the syringe 305 is received in a moving member, which can be driven axially relative to the housing to advance or retract the plunger into the body of the syringe 305. The moving member may be operably coupled to a bracket in the housing, and the bracket may include an internal thread that engages with an external thread of a screw mechanism in the housing, and the screw mechanism may be operably coupled to a motor in the housing. The motor may be operably coupled to a power source (e.g., a replaceable battery or permanent battery in the housing, or coupled to an AC mains power source). In this embodiment, the motor may be activated to rotate the screw mechanism, which in turn may advance or retract (depending on the direction of rotation of the screw mechanism) the moving member, thereby advancing or retracting the plunger handle to drive the fluid out of or into the syringe. For example, the housing of the balloon inflation device 300 may include a deflation button 310 and an inflation button 315. These buttons 310, 315 may be configured so that pressing the corresponding button activates the motor to rotate the screw mechanism in the corresponding rotational direction, which causes the plunger handle to advance or retract at a stable speed rate (and thereby move the volume into or out of the syringe at a substantially stable volume rate), and once the pressure on the button is released, the movement stops. In other embodiments, a single press of the deflation button 310 or the inflation button 315 may activate the motor, and pressing the button again may deactivate the motor. In some embodiments, a third button may be provided that may be activated to stop the motor. It should be understood that during inflation or deflation, the syringe 305 may be connected to the balloon inflation port 1010 of the balloon catheter 1000, wherein the lumen extends from the balloon inflation port 1010, passes through the delivery device containing the artificial heart valve in a curled state, and enters the balloon on which the artificial heart valve is curled. One of the benefits of using the balloon inflation device 300 compared to a manually activated syringe is that the inflation / deflation rate is consistent and allows for controlled inflation and deflation. However, the balloon inflation device 300 still requires the user to be fully responsible for determining the amount of appropriate volume that should be pushed into the balloon to expand the artificial heart valve.

[0043] The balloon inflation device 300 can be modified to provide additional automation. For example, in another embodiment, the balloon inflation device can include an interface that allows a user to input a target volume that should be inflated to the balloon of the balloon catheter 1000. When the user sets the target inflation volume and couples the syringe 305 to the housing of the balloon inflation device 300, the user may only need to press a single button to start the inflation process. The mechanism by which the screw mechanism advances the moving member to depress the handle of the syringe can be the same as the above-mentioned mechanism, wherein the inflation continues at a steady rate for the amount of time required to reach the target inflation volume. The balloon inflation device 300 can be programmed so that once the target inflation volume is reached, the balloon inflation device 300 remains stable for a predetermined amount of time, and then automatically begins to move the plunger handle of the syringe 305 in the opposite direction to deflate the balloon. In such a system, a manual override button is available to stop the process at any desired point. In a similar embodiment, instead of using an off-the-shelf syringe in the outer housing, the balloon inflation device 300 can be built into a delivery device having a fluid reservoir rather than a syringe. If such a system is pre-packaged with an artificial heart valve, the target volume can be set before packaging the system so that no user input is required, and a button or other actuator on the delivery device can be pressed, thereby automating the entire process described above in this paragraph. One of the benefits of these two alternative embodiments is that, in addition to eliminating the need to manually inflate and deflate the balloon, the target volume will be reached in a predictable and controllable manner. In other words, once the target volume is reached, the system automatically stops inflation, effectively eliminating the possibility of inflating the balloon beyond the target volume, which may cause the balloon to rupture and / or damage the patient's tissue.

[0044] In some embodiments, once the balloon has been inflated and the prosthetic heart valve has expanded to the proper position within the native valve annulus, it may be desirable to deflate the balloon very quickly so as to minimize the amount of time that the inflated balloon fills the valve annulus and obstructs blood flow. It should be noted that during transcatheter prosthetic heart valve delivery, the heart may be rapidly paced while the prosthetic valve is deployed. Therefore, it may also or alternatively be desirable to deflate the balloon quickly after the prosthetic heart valve is deployed so as to minimize the amount of time that the heart is rapidly paced. For example, the balloon inflation device 300 (or a similar version thereof) may include a biasing member (e.g., a compression spring 330) having a first end adjacent to the plunger handle 320 of the syringe 305 and a second end adjacent to a platform 325, which may be located on the housing or coupled to the syringe 305. Figure 2BThe motor drive mechanism, generally illustrated as mechanism 335 in the figure, can operate in a similar manner as described above to drive the plunger handle 320 distally to inflate the balloon. However, as the plunger handle 320 is advanced distally, the spring 330 begins to compress, applying a proximal force to the plunger handle 320. The proximal force on the plunger handle 320 is not strong enough to overcome the motor drive mechanism 335 during inflation. However, once the balloon is inflated and the artificial heart valve is deployed, the motor drive mechanism 335 can be decoupled from the plunger handle 320, allowing the spring 330 to quickly decompress, forcing the plunger handle 320 to move proximally, and causing fluid to be quickly withdrawn from the balloon into the body of the syringe 305. Any suitable mechanism can be provided to decouple the motor drive mechanism 335 from the plunger handle 320. For example, if the plunger handle 320 is received in (or coupled to) a moving member (whose moving member is operably coupled to a bracket that engages with a threaded screw mechanism), the coupling between the moving member and the bracket or between the bracket and the threaded screw can be disconnected to allow the compression spring 330 to be decompressed. In other embodiments, a split nut can be used so that the nut is formed into two or more parts that can be brought together to engage the threads or separated to disengage from the threads, thereby allowing the motor drive mechanism 335 to be quickly decoupled from the plunger handle 320. In other embodiments, a single-sided threaded tooth can be provided that is allowed to translate or "rock" into place to engage or disengage with the threads of the threaded screw mechanism. However, it should be understood that the compression spring 330 is optional. For example, the speed at which the plunger handle 320 is driven by the motor drive mechanism 335 can be fast enough that when the plunger handle 320 is driven proximally to deflate the balloon, the balloon is deflated at a speed sufficient to avoid the duration of blood flow obstruction through the balloon (and / or the duration of rapid cardiac pacing) causing any significant negative consequences to the patient.

[0045] FIG. 3A to FIG. 3BAnother embodiment of a balloon inflation system 400 is illustrated. Similar to the balloon inflation device 300, the balloon inflation system 400 may include a housing 401 that houses one or more components, which may include a motor, one or more batteries, electronics for control and / or communication with other components, etc. The housing 401 may include one or more fixed hangers to receive a syringe 405. In the illustrated embodiment, the distal hanger 402a is provided with an open "C" or "U" shaped configuration so that the distal end of the syringe 405 can be snapped into or out of the distal hanger 402a. A proximal hanger 402b may also be provided, which may have a "C" or "U" shaped bottom hingedly connected to the "C" or "U" shaped top. This configuration may allow the proximal end of the outer body of the syringe 405 to snap into the bottom of the hanger 402b, and the top of the hanger 402b may be closed and connected to the bottom to completely surround the outer body of the syringe 405 to lock the syringe 405 to the housing 401. It should be understood that more or fewer hangers of similar or different designs may be included with housing 401 to help secure syringe 405 to the housing in any suitable manner.

[0046] The balloon inflation system 400 may include a mobile member 406. In the illustrated embodiment, the mobile member 406 includes a "C" or "U" shaped hanger to receive the plunger handle 420 therein, the hanger being attached to a bracket that extends at least partially into the housing 401. The bracket of the mobile member 406 may be generally cylindrical and may include an internal thread that cooperates with an external thread of a screw mechanism (not shown) within the housing that is operably connected to the motor. In some embodiments, the bracket may have the general shape of a "U" beam with a flat face oriented toward the top. The mobile member 406 may be rotationally fixed to the housing 401 via any desired mechanism so that when the screw mechanism is rotated by the motor, the mobile member 406 is further advanced into the housing 401, or further retracted away from the housing 401, depending on the direction of rotation of the screw mechanism. When the plunger handle 420 is coupled to the moving member 406, the advancement of the moving member 406 forces the fluid from the syringe 405 toward the balloon, and the retraction of the moving member 406 withdraws the fluid from the balloon toward the syringe. It should be understood that the motor or other drive mechanism can be located inside or outside the housing 401, and any other suitable mechanism can be used to operably couple the motor or other drive mechanism to the moving member 406 to allow axial drive of the plunger handle 420.

[0047] like FIG. 3A to FIG. 3CAs shown, the distal end of the syringe 405 can be coupled to a conduit 407 that is in fluid communication with a lumen of a balloon 480 (e.g., a lumen of a balloon catheter) that leads to or near the distal end of the delivery device. The conduit 407 can allow fluid (e.g., saline) to flow from the syringe 405 to the balloon 480, for example, via one or more fluid ports 485 (e.g., a fluid port 485) in the shaft of the balloon catheter 490. Figure 3F shown), and vice versa.

[0048] Despite FIG. 3A to FIG. 3B Although not separately numbered, housing 401 may include one or more cables extending from the housing, for example to allow for the transmission of power (e.g., from an AC mains power source or another component coupled to the cables) and / or the transmission of data, information, control commands, etc. For example, as described in more detail below, one cable may couple housing 401 to handle 450 of a delivery device such that controls on handle 450 may be used to activate balloon inflation system 400 in a desired manner. As described in more detail below, another cable may be coupled to a computer display or similar device to provide information regarding the inflation of balloon 480. However, it should be understood that any transmission of data or information may be provided wirelessly rather than via a wired connection, such as via Bluetooth or other suitable connection.

[0049] Reference now FIG. 3D to FIG. 3E , the handle 450 of the delivery device may include one or more knobs or actuators to manipulate different features of the delivery device. For example, a rotation knob near the center of the handle 450 can provide catheter deflection, while other knobs or actuators (e.g., near the proximal end of the handle 450) can allow rotational adjustment and / or axial adjustment of the balloon 480 (and the artificial heart valve PHV mounted thereon) to help obtain precise alignment between the native valve annulus and the artificial heart valve PHV prior to deployment. It should also be understood that although a single axis is shown and labeled as a balloon catheter 490, the delivery device may include more than one coaxial catheter axis to provide desired functionality, including relative axial movement between catheter axes in a stack, etc.

[0050] Still reference FIG. 3D to FIG. 3E, the handle may include an actuator 410 for controlling the inflation and deflation of the balloon 480 via the control of the balloon inflation system 400. For example, the actuator 410 may be in the form of a sliding button having a neutral center position and may be pushed distally to inflate the balloon 480 and pulled proximally to deflate the balloon 480. In one example, the actuator 410 remains in the distal position or the proximal position after moving from the neutral position. In another embodiment, the actuator 410 may be biased to a neutral position so that once the user releases the force applied to the actuator 410, the actuator 410 automatically moves back to the neutral position in which fluid neither enters nor is withdrawn from the balloon 480. It should be understood that when sliding the actuator 410 forward or backward, a control signal can be sent from the handle 450 (e.g., via a cable) to the balloon inflation system 400, causing the motor to drive the moving member 406 forward or backward to push the fluid toward the balloon 480 or withdraw the fluid from the balloon 480. FIG. 3D to FIG. 3E An example of a sliding actuator 410 is shown in FIG. 4 , but it should be understood that other actuators (eg, separate buttons, rotation knobs, etc.) may be provided on handle 450 to allow control of balloon inflation system 400 .

[0051] It should also be understood that the actuator 410 can provide a binary control mode, wherein inflation (or deflation) occurs at a set rate, or does not occur at all. In other embodiments, the actuator 410 can have a variable inflation speed control. For example, the user can be able to press the actuator 410 toward the distal end (or proximal end), and the greater the degree to which the user presses the actuator toward the distal end (or proximal end), the faster the balloon inflation system 400 inflates (or deflates) the balloon 480. This variable volume flow rate can be desirable to allow the user to more finely control the inflation or deflation of the balloon 480, which may be particularly useful when the balloon is close to reaching a target size / volume.

[0052] refer to Figure 3F , an example of a prosthetic heart valve PHV (which may include a stent similar to stent 100) is shown curled over a balloon 480 of a balloon catheter 490 while the balloon 480 is in a deflated state. Upon sliding the actuator 410 distally, the balloon inflation system 400 pumps fluid from a syringe 405 into the balloon 480 (e.g., through a lumen within the balloon catheter 490 and into one or more ports 485 located within the interior of the balloon 480). Figure 3GIn a specific illustrated example (the prosthetic heart valve PHV is omitted in this figure), the first port 485 can be one or more holes in the side wall of the balloon catheter 490, and the second port 485 can be the distal open end of the balloon catheter 490, which can terminate within the interior space of the balloon 480.

[0053] The balloon inflation system 400 can be used in a semi-manual method in which pressure or other sensors do not provide real-time feedback to the user. In such an example, when the artificial heart valve PHV is curled on the deflated balloon 480, the distal end of the delivery device can be delivered into the patient's body. For example, with or without the help of a steering mechanism (e.g., a pull line connecting the handle 450 to the distal portion of the balloon catheter 490), the distal end of the delivery device can be advanced through the patient's femoral artery and ultimately turned to pass through the aortic arch. Once the artificial heart valve PHV is positioned in the natural aortic valve ring, the balloon 480 can be inflated and the artificial heart valve PHV can be expanded into the natural aortic valve ring. The deployment can be performed while the patient's heart is rapidly paced. To inflate the balloon 480, the user can slide the actuator 410 distally, which sends a signal to the balloon inflation system 400 to begin driving the moving member 406 distally, which causes the plunger handle 420 to be depressed, forcing the fluid (e.g., saline) in the syringe 405 through the conduit 407, through the balloon catheter 409 and into the balloon 480, causing the balloon to be expanded and forcing the artificial heart valve PHV to expand into the native aortic valve ring. The user can visualize this process, for example, under fluoroscopy, and when the user confirms that the artificial heart valve PHV is at the desired size and position, the actuator 410 can slide proximally to reverse the directional movement of the moving member 406, so that the fluid is withdrawn from the balloon 480 into the syringe 405, thereby causing the balloon 480 to deflate. As the balloon 480 is deflated and the artificial heart valve PHV is expanded in place, the rapid pacing of the heart can be stopped and the heart can begin beating normally again, with the artificial heart valve PHV now regulating blood flow between the left ventricle and the aorta. In some embodiments, the user can enter the target inflation volume or maximum inflation volume directly into the balloon inflation system 400 (e.g., via a user interface provided thereon) or into a computer operably connected to the balloon inflation system 400. If such a target inflation volume or maximum inflation volume is used, the motor in the balloon inflation system can be programmed to shut down once the balloon inflation system 400 has pushed the target inflation volume out of the syringe 405. In some embodiments, for example, if the user determines that additional balloon expansion is needed to properly expand the artificial heart valve PHV into the natural aortic valve ring, the target inflation volume or maximum inflation volume can be manually overwritten. It should be understood that the volume of fluid moving through the balloon inflation system 400 can be tracked by any suitable method. In one embodiment, the inner diameter of the syringe 405 is known, and the distance traveled by the moving member 406 is known, so the resulting volume exiting (or entering) the syringe 405 can be determined by a simple calculation.In other embodiments, fluid sensors may be incorporated into the system to assist in tracking the total volume of fluid moved into or out of the syringe 405 in real time.

[0054] Although the above-mentioned use of balloon inflation system 400 can provide significant benefits including control and precision compared with the complete manual inflation of previously known balloons to implant artificial heart valves, additional data can be used together with balloon inflation system 400 to provide additional useful features.For example, the pressure in the balloon catheter line can be actively monitored to provide additional data that can be used during the deployment of artificial heart valve PHV.In order to obtain the pressure data in the fluid line of the balloon catheter, one or more pressure sensors can be provided in the fluid path.Such a position can include, for example, in the balloon catheter lumen at the handle 450, in the syringe 405 or adjacent to the syringe 405 (for example, near the tip), or in the balloon 480 (for example, directly on the inner surface of the balloon or in the inner side or outer side of a part of the shaft of the balloon catheter 490 surrounded by the balloon 480).In certain embodiments, the pressure line can be arranged in the balloon catheter, for example, by positioning the sensor housing in the balloon 480 to arrange. Figure 3H An embodiment is shown, wherein pressure sensor 482 is mounted to a portion of the shaft of the balloon catheter 490 in the balloon 480, wherein line connection 484 (e.g., electrical line connection or optical line connection) connects pressure sensor 482 to another component to read and / or transmit sensor information. Pressure sensor 482 can be a sensor based on MEMS, but other types of sensors are also suitable. Placing pressure sensor 482 in balloon 480 can allow direct measurement of the pressure inside the balloon, which can avoid potential errors when pressure measurement is performed away from balloon 480 (such as inflation port or at syringe 405). However, it should be understood that using a pressure sensor that is not directly located in balloon 480 can still provide satisfactory measurement results, and the specific sensing mechanism by which the real-time pressure in the balloon catheter is measured can take any other suitable form.

[0055] It may also be desirable to determine the area and / or diameter of the balloon 480 during inflation. One way in which the area and / or diameter of the balloon 480 may be determined is based on a previously determined relationship between pressure or volume and diameter. For example, for a balloon 480 having a particular configuration, a generally applicable correlation may be determined such that, based on a calculated volume that has been delivered toward the balloon 480, the area and / or diameter of the balloon 480 may be estimated based on a known correlation between pressure or volume and size. Furthermore, if the size of the final desired prosthetic heart valve PHV is known, an algorithm based on the correlation may be applied to determine the total volume that should be pushed into the balloon 480 (or the pressure required to reach the desired size). In other embodiments, a sensor may be disposed on the balloon 480 to provide information about the diameter of the balloon 480. For example, as Fig. 3I As shown, one or more strain gauges 486 may be mounted or otherwise attached to the outer wall of the balloon 480 to provide a direct measurement of the diameter of the balloon 480. The strain gauge 486 may be mounted radially to measure hoop strain, or axially to determine diameter. Generally, if it is desired to measure diameter, radial mounting may be more desirable than axial mounting. The general formula for radial strain in a cylindrical pressure vessel is that radial strain equals the product of pressure and radius divided by the product of modulus and wall thickness. Axial strain is half of radial strain, so it can be used as a less direct measurement of radial strain, which may not be as preferred.

[0056] Figure 4 The balloon compliance curve of balloon 480 is shown, which illustrates the relationship between balloon pressure and balloon volume. The solid line represents the baseline or "open-air" pressure-volume curve 510 when the balloon 480 is inflated and not in contact with other structures. However, once the balloon 480 contacts a surface (such as the aortic valve annulus), the pressure-volume curve shifts from the baseline, as shown by the dashed line 520. Before the balloon 480 is inflated to contact the native aortic valve annulus, the curves 510, 520 are identical. However, upon contact, the pressure-volume curve shifts from the baseline 510 by a certain amount, and the change or difference is represented by arrow 530. The difference 530 is the result of the natural tissue compliance applying a compressive force to the expanded balloon. This information can be used to help determine when the artificial heart valve PHV has expanded to a desired amount. For example, a particular amount of deviation 530 between the baseline pressure-volume curve 510 during implantation and the actual pressure-volume curve 520 can be determined as the amount of deviation 530 that corresponds to optimal prosthetic heart valve PHV expansion within the aortic valve annulus. The value of this expected deviation 530 can be determined, for example, via testing across multiple patients or by analyzing data from multiple actual implantations.

[0057] As described above, the volume of fluid entering the balloon 480 from the syringe 405 can be tracked in real time, and the pressure can also be tracked in real time via one or more of the pressure sensors described above. Furthermore, during valve implantation using the prosthetic heart valve PHV and the balloon inflation system 400, the real-time pressure-volume curve 520 can be displayed for user reference along with the expected baseline pressure-volume curve 510, thereby allowing the user to use the displayed data to confirm the desirability of the procedure or otherwise alter the procedure based on the data.

[0058] For example, Figure 5 6 is a schematic representation of a surgical setting including a first user (e.g., physician 600), a second user (e.g., support personnel 610), an operating table 620 for a patient, one or more computers and / or displays 630, a balloon inflation system 400, and a delivery device including a handle 450. Before further detailing specific examples of intraoperative use of data obtained during surgery, some of the various interactions within the setting are briefly described below. As described above and as reiterated herein, fluid can be transferred in either direction between the balloon inflation system 400 and the handle 450 of the delivery system, and command signals for activating the balloon inflation system 400 can be transferred from the handle 450 to the balloon inflation system 400. The physician 600 can manually control the delivery system, including implanting a prosthetic heart valve PHV into a patient on the table 620 using the handle 450, including control of inflation and deflation of the balloon 450 via the actuator 410. During the procedure, data obtained from the procedure (e.g., the volume that has been transferred from the balloon inflation system 400 toward the balloon 480 (or vice versa), the current area of ​​the balloon 480 (which can be calculated based on the fluid volume), and the current pressure within the system) can be transmitted to and / or displayed on one or more computers and / or displays 630. As described above, data transmission can be via a wired or wireless connection. The physician 600 can view the display 630, which can include the above data as well as other information (e.g., fluoroscopic images of the patient's anatomy). The support staff 610 can similarly view the data on the display 630, and the physician 600 or the support staff 610 can input parameters (e.g., a target volume for inflation of the balloon 680) via the computer and / or display 630. The computer and / or display 630 may then communicate these parameters to the balloon inflation system 400 (eg, by setting a target volume) so that the balloon inflation system 400 does not inflate the balloon 480 beyond the target volume unless the user 600 , 610 overrides the balloon inflation system 400 .

[0059] Fig. 6AAn exemplary screen that may be displayed on a computer and / or display 630 as part of the planning phase prior to implanting a prosthetic heart valve PHV into a patient is illustrated. In this exemplary screen, one or more inputs may be entered for use during the procedure. One exemplary input is the target annular area, which represents the size of the patient's native annulus. In this particular example, the value entered is 623 mm 2 Another exemplary input is a desired oversizing percentage for the prosthetic heart valve PHV. In other words, it is generally desirable to target an area / size of the prosthetic heart valve PHV that is larger than the area / size of the patient's native valve annulus, e.g., to create sufficient friction to help keep the prosthetic heart valve PHV in place during normal operation of the prosthetic heart valve PHV. In this particular example, a value of 5.3% is entered for the oversizing percentage. It should be understood that the value of 5.3% is not necessarily the same as the value of 5.3% for the prosthetic heart valve PHV. Fig. 6A and Figure 6B All numbers and values ​​provided are exemplary only and are not intended to be limiting, but rather to illustrate an example of input and output in order to better illustrate the relevant concepts. Based on the input during the planning phase, certain outputs may be provided for review and confirmation by the physician 600 and / or support staff 610, such as a target area for the artificial heart valve PHV, which may be calculated by applying the oversize percentage to the annular area of ​​the patient. An artificial heart valve PHV of a specific size may also be suggested by the output. For example, an artificial heart valve PHV is typically provided in different size options, and the physician 600 will select the appropriate size option for a particular patient. In this example, based on the input, the recommended artificial heart valve PHV size is 29 mm. Another output that may be provided to the user 600, 610 is a suggested total inflation volume, which should be pushed from the balloon inflation system 400 to achieve the desired expansion size of the artificial heart valve PHV. In this particular example, the suggested total inflation volume is 33 mL. The suggested inflation volume may be provided based on, for example, a predetermined correlation derived from testing that correlates inflation volume and valve area when the balloon 480 is expanded. Another output that may be provided is a target pressure for the balloon 480 to achieve the desired expanded size of the prosthetic heart valve PHV. In this particular example, the target pressure is provided as 6.3 atm. It should be understood that while various recommended values ​​are output based on input data, the physician 600 has control to override the recommended values ​​based on his or her experience.

[0060] Figure 6B The diagram shows an example of a computer and / or display 630 that can be displayed as Fig. 6A An exemplary screen of a portion of the intraoperative phase of implanting a prosthetic heart valve PHV into a patient following the planning phase is shown. The patient's annular area and the Fig. 6AThe selected size of the prosthetic heart valve PHV during the planning phase as well as the current status of the procedure (e.g. “inflated” or “deflated”) can be displayed on the Figure 6B on the screen during surgery. Figure 6B The in-operation screen of the embodiment may show multiple sections providing current and target operation parameters to assist the user 600, 610 in understanding the progress of deployment of the prosthetic heart valve PHV. For example, the valve area section may provide a target prosthetic heart valve PHV expansion size / area compared to the current prosthetic heart valve PHV expansion size / area during inflation of the balloon 680. The illustrated screen 630 shows the previously selected target size of 656 mm. 2 The current inflated size of the PHV with prosthetic heart valve is 326mm 2 In addition to providing these values, a graph (e.g., a progress bar) may be shown that illustrates a comparison of the current expanded size as a percentage of the patient's valve annulus size with the desired expanded size as a percentage of the patient's valve annulus size. The progress bar indicates the target value for the planning stage (in this case, 5.4% oversize) (e.g., 105.4% of the patient's valve annulus size), as well as the current status (e.g., the size during surgery for the artificial heart valve PHV is 56.0% of the patient's valve annulus size). Similar information panels with progress bars may be provided for other parameters, such as the current balloon pressure (e.g., 6.0 atm) versus the planned target balloon pressure (e.g., 6.4 atm). Another information panel for the current inflation volume (e.g., 27.2 mL at the stage of surgery shown) versus the target inflation volume (e.g., 33.2 mL in the planning stage) may be provided along with the graphical representation (e.g., via a progress bar including an indicator of the target inflation volume).

[0061] Figure 6B Also illustrated is a graph that plots the pressure within balloon 480 versus the area of ​​balloon 480 as the procedure continues. Figure 4 In the example of the compliance curve in FIG. 5 , a baseline pressure-area curve 510 can be provided as a static, known relationship that is expected to be used to inflate the balloon 480 in the "open air." As the balloon 480 is inflated, an actual surgical pressure-area curve 520 can be plotted when the pressure is detected and the area is sensed (e.g., using a strain gauge 486) or calculated (e.g., based on a known correlation between the fluid volume and area of ​​the balloon 480). Figure 6B As shown, there is a deviation 530 between the pressure-area curve 520 during surgery and the baseline pressure-area curve 610. It should be understood that Figure 6BThe large deviation 530 shown in is for illustrative purposes only, and the deviation 530 of the size shown is not intended to represent the actual expected level of deviation. Regardless, the deviation 530 between the baseline curve 510 and the curve 520 during surgery can provide important information to the user 600, 610, which can be used to confirm that the operation is proceeding as expected, or to confirm that a potential problem that needs to be investigated and / or resolved has otherwise occurred. For example, as described above, a known target deviation 530 between the baseline curve 510 and the curve 520 during surgery can be set or understood as the desired deviation. If the illustrated deviation 530 is close to or equal to the target deviation 530, and other target parameters (e.g., artificial heart valve PHV size, balloon pressure and / or inflation volume) are at or close to their target values, the doctor 600 can determine that the operation has met all goals and the artificial heart valve PHV has been properly deployed. It should be understood that the doctor 600 can use other information (including fluoroscopic images and his or her general experience and knowledge) to assist in this determination. However, if the pressure-area curve 520 of the procedure deviates significantly from the baseline curve 510 beyond expectations, such deviation 530 may indicate a potential problem. Figure 6B In the example shown, the pressure of the balloon 480 has increased much faster than expected, which means that although the artificial heart valve PHV has only partially expanded toward the target size, the balloon 480 and the artificial heart valve PHV are experiencing a significantly greater force than expected, which may be the result of the natural tissue pressing the artificial heart valve PHV. The cause of this deviation may include, for example, incorrect measurement of the size of the patient's valve ring and / or the calcification of the natural valve is significantly greater than expected. If the doctor 600 continues to inflate the balloon 480 despite the large deviation 530 shown, the valve ring and / or the balloon 480 may be at risk of rupture. In turn, the doctor 600 can use the actuator 410 on the handle 450 to pause the inflation of the balloon 480, and evaluate the situation to determine the cause of the deviation 530, and the operation can be adjusted accordingly. In some embodiments, the doctor 600 or the support staff 610 can interact with the computer and / or the display 630 to update the target parameters based on the information learned from the evaluation after the inflation is paused. In some embodiments, the physician 600 or support staff 610 can view in vivo fluoroscopic images for valve dilation and if the prosthetic heart valve is believed to be anchored, the balloon can be deflated for further investigation using, for example, fluoroscopy and contrast injection.

[0062] In some embodiments, the computer and / or display 630 may be programmed to provide an alert to the user 600, 610 when a parameter approaches, reaches, and / or exceeds a target parameter. Such an alert may be purely informational, or may otherwise result in a surgical change. For example, when the sensed pressure of the balloon 480 reaches the target pressure (or otherwise exceeds the target pressure, or exceeds a predetermined buffer value of the target pressure, such as 5%), then the computer and / or display 630 may generate a purely informational alert that the target pressure has been reached or exceeded (reached or exceeded any amount or predetermined buffer amount), or may generate an alert that also signals the balloon inflation system 400 to stop inflating the balloon 480. If the alert causes such an action, the user 600, 610 will be able to override the alert by, for example, disabling the alert via interaction with the computer and / or display 630, and then continue to inflate the balloon 480 if it is deemed appropriate to do so. Other similar types of alerts for other target values ​​may similarly be provided.

[0063] Information from the surgery may be useful not only for that particular surgery, but data from multiple surgeries can be aggregated and used to inform how to optimize subsequent surgeries. For example, a database of information (preferably anonymized patient information) can be created that stores information related to the parameters encountered during a particular surgery and the results of the surgery. As a specific example, the effectiveness of inflating the balloon 480 to a specific pressure and a specific size, as well as the final effectiveness of the implant, can be stored in a database, taking into account the size of the patient's native annulus. With enough data, the desired target parameters for future patients can be determined based on previous surgical results. For example, if a patient of a specific age, gender, and a native aortic valve annulus of a specific size is a candidate for artificial heart valve PHV implantation, the patient's information can be compared with other similar patients who have undergone artificial heart valve PHV implantation, and the target parameters for future patient surgery can be based at least in part on the actual parameters found in previous similar patients who have successfully undergone artificial heart valve PHV implantation. As more data accumulates, more accurate and complex algorithms can be created to predict target surgical parameters for individual patients to optimize patient outcomes. For example, with sufficient data from previous surgeries, the system can become highly sensitive and be able to determine subtle changes in the delivery and / or deployment of the artificial heart valve PHV based on the recognition of detected patterns of pressure changes. For example, the system can alert the user to initial contact with tissue based on subtle changes in pressure readings during the deployment of the artificial heart valve PHV within the valve ring. Other situations can provide characteristic pressure readings (e.g., contact with highly calcified tissue, tearing of any natural tissue due to balloon expansion force, etc.). The system can alert the user to each of these scenarios based on the detected characteristic pressure change readings. And it should be understood that these characteristic pressure change readings are not necessarily limited to the deployment stage of the artificial heart valve PHV, but can be detected during the delivery after the artificial heart valve PHV has been introduced into the vascular system. For example, during the delivery of the artificial heart valve PHV, the system can detect characteristic pressure change readings indicating certain events (e.g., the offset position of the artificial heart valve PHV relative to the balloon, the contact of the artificial heart valve PHV with the luminal tissue of the vascular system, etc.).

[0064] Although the above-mentioned balloon inflation system can provide significant utility in inflating the balloon 480 during the implantation of the artificial heart valve PHV, the balloon inflation system can also be useful in preparing the balloon catheter for later use (including, for example, degassing the system). During the use of the above-mentioned balloon catheter 490, the internal fluid pipeline in the balloon catheter 490 and extending into the syringe 405 is a closed system. It is generally important that the amount of air in the closed system is minimized. There may be problems or potential problems with air in the system. For example, if the balloon 480 ruptures and there is air in the system, the air may be released into the blood flow, which may cause blood flow obstruction, thereby causing a stroke or another medical crisis. In addition, the air in the system may cause pressure or other readings to be less accurate than when there is no air (or air with a minimum acceptable level) in the system. Currently, to degas a balloon catheter prior to use, a manual process is performed in which a vacuum is created in the balloon catheter using a first syringe, a fluid is then pushed into the balloon catheter using a separate syringe, and the cycle is repeated to fill the balloon catheter with fluid and purge any remaining air in the balloon catheter. However, to confirm that there is no air (or a minimum acceptable level of air) in the balloon catheter, a visual inspection is performed, which can be a relatively subjective analysis that can have a potentially high risk of error due to the human factor involved. The balloon inflation system described herein can be used to automate the degassing process while also producing a more objective, data-based confirmation of the amount of air remaining in the balloon catheter after the degassing procedure.

[0065] Figure 7 is a schematic diagram of a diagram of a degassing system including a fill syringe 405 and a purge syringe 705. The fill syringe 405 and the purge syringe 705 can be substantially identical, and each can be part of a balloon inflation system similar to the system 400 described above. Each syringe 405, 705 can be fluidly coupled to the balloon catheter 490 via a three-way stopcock 730 that allows any component of the system to be fluidly isolated from the other two components. An air trap 710 can be positioned between the purge syringe 604 and the valve 730, with a one-way check valve 720 positioned downstream of the air trap 710.

[0066] exist Figure 7In an exemplary use of the degassing system, the balloon catheter 490 is initially free of fluid. The inflation syringe 405 is pre-filled with the desired fluid (typically saline), wherein the inflation syringe plunger 408 is positioned at the proximal end, and the plunger 708 of the purging syringe plunger 708 is fully advanced distally. When in this position, the syringes 405, 705 are connected to the balloon catheter 490 via the three-way valve 730. The three-way valve 730 is positioned so that the syringes 405, 705 are in fluid communication with each other, but isolated from the balloon catheter 490. When the three-way valve 730 is in this position, the plunger 408 of the inflation syringe 405 is depressed, pushing the fluid toward the purging syringe 705. During this step, the air in the line is purged via the air trap 710 and the check valve 720. It should be understood that during this step, a relatively small percentage of the fluid in the inflation syringe 405 can leave the inflation syringe 405. Next, the three-way valve 730 is positioned to fluidically connect the purging syringe 705 and the balloon catheter 490, thereby isolating the inflation syringe 405 from other components. The plunger 708 of the purging syringe 705 is withdrawn to create a vacuum in the balloon catheter 490. During this step, which can be referred to as the first step, the pressure in the balloon catheter 490 can be measured using any suitable pressure sensor device (including those described above) and recorded as a function of the displacement of the purging syringe plunger 708. While maintaining the vacuum, the three-way valve 730 can be positioned to fluidically connect the balloon catheter 490 and the inflation syringe 405, thereby isolating the purging syringe 705. During this step, which can be referred to as the second step, the plunger 408 is advanced distally to push the fluid (or allow the fluid to be pulled because of the vacuum) into the balloon catheter 490. Then, the three-way valve is positioned to fluidically connect the syringes 405, 705, thereby isolating the balloon catheter 490. In this step, which may be referred to as the third step, the plunger 408 may be depressed to force the air trapped in the air catcher 710 out of the check valve 720. The process of steps referred to as the first step, the second step, and the third step may be repeated in sequence, measuring and recording the pressure and displacement of the plunger 708 during the first step of each cycle.

[0067] As described above, during each cycle of the degassing process, pressure and displacement measurements are recorded as the purge syringe 705 is fluidically connected to the balloon catheter 490 and a vacuum is drawn. When air is present in the balloon catheter 490, the vacuum pressure achieved during this first step is relatively small because the air in the system expands into the purge syringe 705. However, during each cycle of the steps referred to above as the first step, the second step, and the third step, a certain amount of air is purged from the system. Furthermore, when the vacuum is drawn by the purge syringe 705 a second time, there is less air in the system than in the previous cycle, and the vacuum pressure achieved is greater than in the first cycle. As the cycle is repeated and more air is purged from the system, the vacuum pressure generated by a given displacement of the purge syringe plunger 708 increases. As Figure 8 As shown, during each purge cycle, as more air is removed from the system, the slope of the relationship between vacuum pressure and displacement increases. Because these slopes generally follow a mathematical model, a threshold slope representing when the amount of air remaining in the balloon catheter 490 is at an acceptable level can be determined. Therefore, the purge cycle can continue until the slope of vacuum pressure and syringe displacement is greater than or equal to a minimum threshold slope. At this point, the balloon catheter 490 has been fully purged so that the amount of air remaining in the balloon catheter 490 does not exceed an acceptable amount. In a similar but alternative embodiment, the minimum vacuum level for a given syringe displacement can also be set to a threshold level that, when passed through this threshold level, indicates that the remaining air in the balloon catheter 490 does not exceed an acceptable level.

[0068] It should be understood that the use of a motorized syringe system to perform degassing, and the measurement of vacuum pressure versus displacement of the purging syringe can be used alone or together, and that each approach has benefits. For example, even if a final check for air in the system is performed manually through visual inspection, automation of the degassing system simplifies the preparation of the balloon catheter 490. Similarly, even if degassing is performed manually using a syringe, pressure versus displacement measurements can still be utilized to eliminate the need to rely on visual inspection to confirm that the balloon catheter 490 has been properly degassed. Most preferably, automation is combined with pressure measurement to provide a simple and rapid degassing process that relies on objective measurements to determine when the balloon catheter 490 has been properly degassed. Finally, it should be understood that although combined with the degassing system, the degassing process can be performed manually through visual inspection. Figure 7 The described degassing system is shown as a separate component, but the system can be built into the handle 450 of the delivery system so that a physically separate system is not required to perform the degassing process.

[0069] According to one aspect of the present disclosure, a method for implanting an artificial heart valve comprises:

[0070] delivering a prosthetic heart valve to a native valve annulus while crimping the prosthetic heart valve onto a deflated balloon of a delivery device;

[0071] Propelling a fluid through the delivery device and into the balloon to inflate the balloon and cause the prosthetic heart valve to expand into the native valve annulus;

[0072] monitoring pressure within the delivery device while advancing fluid through the delivery device; and

[0073] During the pressure monitoring, displaying the monitored pressure in real time on the display device; and / or

[0074] Displaying the monitored pressure in real time on a display device includes displaying the monitored pressure as a surgical curve as a function of the area of ​​the balloon; and / or

[0075] determining the area of ​​the balloon based on the monitored pressure, and determining the monitored pressure by measuring the pressure within a fluid line in which the fluid is advanced; and / or

[0076] estimating the area of ​​the balloon based on the volume of fluid propelled through the delivery device; and / or

[0077] determining the area of ​​the balloon based on a strain gauge mounted on the balloon; and / or

[0078] displaying a reference curve of pressure as a function of balloon area on a display device; and / or

[0079] The reference curve is based on an expected relationship between the pressure of the balloon and the area of ​​the balloon when the balloon is expanded in free space; and / or

[0080] monitoring a difference between a surgical curve and a reference curve while advancing a fluid through a delivery device to expand a prosthetic heart valve; and / or

[0081] Advancing the fluid through the delivery device includes actuating an actuator on a handle of the delivery device; and / or

[0082] An actuator on the handle of the actuated delivery device sends a signal to a motorized housing having a syringe containing a fluid, which causes the motorized housing to depress the plunger of the syringe.

[0083] According to another aspect of the present disclosure, a prosthetic heart valve delivery system comprises:

[0084] handle;

[0085] a balloon catheter extending from the handle;

[0086] a balloon positioned at a distal portion of the balloon catheter;

[0087] a fluid reservoir in fluid communication with the lumen in fluid communication with the interior volume of the balloon;

[0088] a motor operably coupled to the fluid reservoir; and

[0089] an actuator on the handle, the actuator operably coupled to the motor such that actuation of the actuator in a first direction causes the motor to push fluid from the fluid reservoir through the lumen toward the interior volume of the balloon, and actuation of the actuator in a second direction opposite the first direction causes the motor to withdraw fluid from the interior volume of the balloon toward the fluid reservoir; and / or

[0090] The fluid reservoir and motor are contained within the handle; and / or

[0091] The fluid reservoir is located in a syringe coupled to the housing to receive the syringe, the motor being positioned within the housing; and / or

[0092] a pressure sensor configured to determine the pressure within the balloon; and / or

[0093] The pressure sensor is positioned directly within the balloon; and / or

[0094] A strain gauge is mounted on the balloon.

[0095] According to yet another aspect of the present disclosure, a method for degassing a balloon of a balloon catheter comprises:

[0096] (i) withdrawing a plunger of a purging syringe while the purging syringe is in fluid communication with a balloon of a balloon catheter and the purging syringe is not in fluid communication with a fill syringe containing a fluid, and monitoring vacuum pressure as a function of plunger displacement while the plunger of the purging syringe is withdrawn to create a pressure-displacement line having a slope;

[0097] (ii) advancing a plunger of the filling syringe while the filling syringe is in fluid communication with the balloon of the balloon catheter and the filling syringe is not in fluid communication with the purging syringe;

[0098] (iii) advancing a plunger of the filling syringe while the filling syringe is in fluid communication with the purging syringe and the filling syringe is not in fluid communication with the balloon catheter to force remaining air through a one-way valve in fluid communication with the purging syringe; and

[0099] Repeating steps (i) to (iii) until the slope of the pressure-displacement line exceeds a threshold slope of a reference pressure-displacement line; and / or

[0100] Monitoring vacuum pressure using a pressure sensor in fluid communication with the purge syringe; and / or

[0101] The plunger of the filling syringe and the plunger of the clearing syringe are each operably coupled to the motor system; and / or

[0102] automatically performing the steps of withdrawing the plunger of the clearing syringe and advancing the plunger of the filling syringe via a motor system; and / or

[0103] A three-way valve is positioned between the filling syringe, the purging syringe, and the balloon catheter, and can be actuated to fluidly connect any two of the filling syringe, the purging syringe, and the balloon catheter at a given time.

[0104] Although the present invention has been described with respect to specific embodiments, it should be understood that these embodiments are merely exemplary of the principles and applications of the present invention. Therefore, it should be understood that many changes may be made to the exemplary embodiments and other arrangements may be designed without departing from the spirit and scope of the present invention as defined in the appended claims.

Claims

1. A method for implanting an artificial heart valve, the method comprising: delivering the artificial heart valve to the native valve annulus while crimping the artificial heart valve on the deflated balloon of the delivery device; Propelling a fluid through the delivery device and into the balloon to inflate the balloon and expand the prosthetic heart valve into the native valve annulus; monitoring pressure within the delivery device while advancing fluid through the delivery device; as well as During the monitoring of the pressure, the monitored pressure is displayed in real time on the display device.

2. The method of claim 1, wherein displaying the monitored pressure in real time on the display device comprises displaying the monitored pressure as a surgical curve as a function of the area of ​​the balloon.

3. The method of claim 2, wherein the area of ​​the balloon is determined based on the monitored pressure, and the monitored pressure is determined by measuring the pressure within a fluid line in which the fluid is propelled.

4. The method of claim 2, wherein the area of ​​the balloon is estimated based on the volume of fluid advanced through the delivery device.

5. The method of claim 2, wherein the area of ​​the balloon is determined based on a strain gauge mounted on the balloon.

6. The method of claim 2, further comprising displaying a reference curve of pressure as a function of balloon area on the display device.

7. The method of claim 6, wherein the reference curve is based on an expected relationship between the pressure of the balloon and the area of ​​the balloon when the balloon is expanded in free space.

8. The method of claim 7, further comprising monitoring a difference between the surgical curve and the reference curve while advancing fluid through the delivery device to cause the prosthetic heart valve to expand.

9. The method of claim 1, wherein advancing the fluid through the delivery device comprises actuating an actuator on a handle of the delivery device.

10. The method of claim 9, wherein actuating the actuator on the handle of the delivery device sends a signal to a motorized housing having a syringe containing the fluid, the signal causing the motorized housing to depress a plunger of the syringe.

11. An artificial heart valve delivery system, comprising: handle; a balloon catheter extending from the handle; a balloon positioned at a distal portion of the balloon catheter; a fluid reservoir in fluid communication with the lumen, the lumen in fluid communication with the interior volume of the balloon; a motor operably coupled to the fluid reservoir; as well as an actuator located on the handle, the actuator being operably connected to the motor such that actuation of the actuator in a first direction causes the motor to push fluid from the fluid reservoir through the lumen toward the interior volume of the balloon, and actuation of the actuator in a second direction opposite to the first direction causes the motor to withdraw fluid from the interior volume of the balloon toward the fluid reservoir.

12. An artificial heart valve delivery system according to claim 11, wherein the fluid reservoir and the motor are contained within the handle.

13. The prosthetic heart valve delivery system of claim 11, wherein the fluid reservoir is located in a syringe, the syringe being coupled to a housing to receive the syringe, the motor being positioned within the housing.

14. The prosthetic heart valve delivery system of claim 11, further comprising a pressure sensor configured to determine the pressure within the balloon.

15. An artificial heart valve delivery system according to claim 14, wherein the pressure sensor is positioned directly within the balloon.

16. The prosthetic heart valve delivery system of claim 14, further comprising a strain gauge mounted on the balloon.

17. A method for degassing a balloon of a balloon catheter, the method comprising: (i) withdrawing a plunger of a purging syringe while the purging syringe is in fluid communication with the balloon of the balloon catheter and the purging syringe is not in fluid communication with a fill syringe containing a fluid, and monitoring vacuum pressure as a function of plunger displacement while the plunger of the purging syringe is withdrawn to create a pressure-displacement line having a slope; (ii) advancing a plunger of the filling syringe while the filling syringe is in fluid communication with the balloon of the balloon catheter and the filling syringe is not in fluid communication with the purging syringe; (iii) advancing a plunger of the filling syringe while the filling syringe is in fluid communication with the purging syringe and the filling syringe is not in fluid communication with the balloon catheter to force remaining air through a one-way valve in fluid communication with the purging syringe; as well as Steps (i) to (iii) are repeated until the slope of the pressure-displacement line exceeds a threshold slope of a reference pressure-displacement line.

18. The method of claim 17, wherein the vacuum pressure is monitored using a pressure sensor in fluid communication with the purging syringe.

19. The method of claim 18, wherein each of the plunger of the filling syringe and the plunger of the clearing syringe are operably coupled to a motor system.

20. The method of claim 19, wherein the steps of withdrawing the plunger of the purging syringe and advancing the plunger of the filling syringe are performed automatically via the motor system.

21. The method of claim 17, wherein a three-way valve is positioned between the filling syringe, the purging syringe, and the balloon catheter, the three-way valve being actuatable to fluidly connect any two of the filling syringe, the purging syringe, and the balloon catheter at a given time.